Treprostinil Iontophoresis in Systemic Sclerosis Digital UlcErations. A Proof of Concept Study
Status:
Completed
Trial end date:
2019-06-03
Target enrollment:
Participant gender:
Summary
The study is conducted to confirm the good tolerance of a continuous cathodal iontophoresis
of the treprostinil hydrogel administered during 10 days on the pulp of the finger of healthy
volunteer and on the ischemic digital ulcerations of Systemic Sclerosis patients,
particularly to estimate the cutaneous tolerance of the procedure and the effect on the blood
pressure.